UTILISATION D'UNE PYRAZOLO[4,3-D]PYRIMIDINE TETRASUBSTITUEE POUR LE TRAITEMENT DE LA NEPHROPATHIE DIABETIQUE

• 收藏
• 分享

专利权人:

PFIZER INC.

发明人:

CLERIN, VALERIE,GALE, JEREMY,TAMIMI, NIHAD

申请号：

CA2888160

公开号：

CA2888160A1

申请日:

2013.10.09

申请国别(地区):

CA

年份:

2014

代理人:

摘要：

The present invention relates to methods of delaying progression to end stage renal disease (ESRD) in patients comprising administration of 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide. The present invention also includes administration of pharmaceutical compositions for delaying progression to ESRD. 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/